SCHEMBL9056372

SCHEMBL9056372

O=C1Nc2ccccc2C/C1=N/O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AHR P35869 1/20 0.53
▸ PDK2 Q15119 1/20 0.53
▸ ALDH1A1 P00352 3/20 0.51
▸ CYP1A2 P05177 2/20 0.51
▸ CYP2C19 P33261 1/20 0.51
▸ NPC1 O15118 2/20 0.44
▸ MAPT P10636 2/20 0.44
▸ KDM4E B2RXH2 1/20 0.44
▸ MEN1 O00255 1/20 0.44
▸ HSP90AA1 P07900 1/20 0.44
▸ THRB P10828 1/20 0.44
▸ HK1 P19367 1/20 0.44
▸ MAPK1 P28482 1/20 0.44
▸ RECQL P46063 1/20 0.44
▸ RAB9A P51151 1/20 0.44
▸ GALK1 P51570 1/20 0.44
▸ BLM P54132 1/20 0.44
▸ KMT2A Q03164 1/20 0.44
▸ HKDC1 Q2TB90 1/20 0.44
▸ MAPK13 O15264 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9056376 1.00 AHR (0.53) AHRPDK2ALDH1A1CYP1A2CYP2C19
SCHEMBL2217338 0.84 NPC1 (0.55) AHRPDK2ALDH1A1CYP1A2CYP2C19
SCHEMBL3456349 0.84 NPC1 (0.55) AHRPDK2ALDH1A1CYP1A2CYP2C19
SCHEMBL3458619 0.81 LRRK2 (0.48) ALDH1A1CYP1A2CYP2C19MAPTKDM4E
SCHEMBL9551793 0.79 LRRK2 (0.50) AHRPDK2ALDH1A1CYP1A2CYP2C19
Acridan SCHEMBL5475312 0.75 AHR (0.57) AHRPDK2ALDH1A1CYP1A2NPC1
SCHEMBL1816980 0.75 AHR (0.63) AHRPDK2CYP1A2NPC1MAPT
SCHEMBL6249305 0.73 AHR (0.61) AHRPDK2CYP1A2NPC1MAPT
SCHEMBL4356821 0.72 AHR (0.59) AHRPDK2CYP1A2NPC1MAPT
SCHEMBL2087698 0.72 TDP2 (0.66) AHRPDK2CYP1A2NPC1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1996040141-A1 4,5-BRIDGED QUINOXALINEDIONES AND QUINOLONES AND THE USE THEREOF AS EXCITATORY AMINO ACID RECEPTOR ANTAGONISTS ACEA PHARMACEUTICALS, INC. (US) 1996-12-19 — — WO disclosed
Send feedback